BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 22210083)

  • 21. Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p.
    Hsiung GY; DeJesus-Hernandez M; Feldman HH; Sengdy P; Bouchard-Kerr P; Dwosh E; Butler R; Leung B; Fok A; Rutherford NJ; Baker M; Rademakers R; Mackenzie IR
    Brain; 2012 Mar; 135(Pt 3):709-22. PubMed ID: 22344582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia.
    Halliday GM; Kiernan MC; Kril JJ; Mito R; Masuda-Suzukake M; Hasegawa M; McCann H; Bartley L; Dobson-Stone C; Kwok JBJ; Hornberger M; Hodges JR; Tan RH
    J Neurol Sci; 2016 Jul; 366():197-201. PubMed ID: 27288806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive decline in amyotrophic lateral sclerosis: Neuropathological substrate and genetic determinants.
    Borrego-Écija S; Turon-Sans J; Ximelis T; Aldecoa I; Molina-Porcel L; Povedano M; Rubio MA; Gámez J; Cano A; Paré-Curell M; Bajo L; Sotoca J; Clarimón J; Balasa M; Antonell A; Lladó A; Sánchez-Valle R; Rojas-García R; Gelpi E
    Brain Pathol; 2021 May; 31(3):e12942. PubMed ID: 33576076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive phenotypes of sequential staging in amyotrophic lateral sclerosis.
    Lulé D; Böhm S; Müller HP; Aho-Özhan H; Keller J; Gorges M; Loose M; Weishaupt JH; Uttner I; Pinkhardt E; Kassubek J; Del Tredici K; Braak H; Abrahams S; Ludolph AC
    Cortex; 2018 Apr; 101():163-171. PubMed ID: 29477906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion.
    Brettschneider J; Van Deerlin VM; Robinson JL; Kwong L; Lee EB; Ali YO; Safren N; Monteiro MJ; Toledo JB; Elman L; McCluskey L; Irwin DJ; Grossman M; Molina-Porcel L; Lee VM; Trojanowski JQ
    Acta Neuropathol; 2012 Jun; 123(6):825-39. PubMed ID: 22426854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration.
    Woollacott IOC; Toomey CE; Strand C; Courtney R; Benson BC; Rohrer JD; Lashley T
    J Neuroinflammation; 2020 Aug; 17(1):234. PubMed ID: 32778130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer's disease.
    Nag S; Yu L; Boyle PA; Leurgans SE; Bennett DA; Schneider JA
    Acta Neuropathol Commun; 2018 May; 6(1):33. PubMed ID: 29716643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis.
    Brettschneider J; Toledo JB; Van Deerlin VM; Elman L; McCluskey L; Lee VM; Trojanowski JQ
    PLoS One; 2012; 7(6):e39216. PubMed ID: 22720079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapidly progressive amyotrophic lateral sclerosis is associated with microglial reactivity and small heat shock protein expression in reactive astrocytes.
    Gorter RP; Stephenson J; Nutma E; Anink J; de Jonge JC; Baron W; Jahreiβ MC; Belien JAM; van Noort JM; Mijnsbergen C; Aronica E; Amor S
    Neuropathol Appl Neurobiol; 2019 Aug; 45(5):459-475. PubMed ID: 30346063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLD.
    Shenouda M; Zhang AB; Weichert A; Robertson J
    Adv Neurobiol; 2018; 20():239-263. PubMed ID: 29916022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia.
    Zhang H; Tan CF; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
    Acta Neuropathol; 2008 Jan; 115(1):115-22. PubMed ID: 17786458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct TDP-43 inclusion morphologies in frontotemporal lobar degeneration with and without amyotrophic lateral sclerosis.
    Tan RH; Yang Y; Kim WS; Dobson-Stone C; Kwok JB; Kiernan MC; Halliday GM
    Acta Neuropathol Commun; 2017 Oct; 5(1):76. PubMed ID: 29078806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis.
    Irwin DJ; McMillan CT; Brettschneider J; Libon DJ; Powers J; Rascovsky K; Toledo JB; Boller A; Bekisz J; Chandrasekaran K; Wood EM; Shaw LM; Woo JH; Cook PA; Wolk DA; Arnold SE; Van Deerlin VM; McCluskey LF; Elman L; Lee VM; Trojanowski JQ; Grossman M
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):163-9. PubMed ID: 23117491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: their relation to AD common pathology.
    Kadokura A; Yamazaki T; Lemere CA; Takatama M; Okamoto K
    Neuropathology; 2009 Oct; 29(5):566-73. PubMed ID: 19422539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression.
    Quek H; Cuní-López C; Stewart R; Colletti T; Notaro A; Nguyen TH; Sun Y; Guo CC; Lupton MK; Roberts TL; Lim YC; Oikari LE; La Bella V; White AR
    J Neuroinflammation; 2022 Feb; 19(1):58. PubMed ID: 35227277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frontotemporal dementia-amyotrophic lateral sclerosis syndrome locus on chromosome 16p12.1-q12.2: genetic, clinical and neuropathological analysis.
    Dobson-Stone C; Luty AA; Thompson EM; Blumbergs P; Brooks WS; Short CL; Field CD; Panegyres PK; Hecker J; Solski JA; Blair IP; Fullerton JM; Halliday GM; Schofield PR; Kwok JB
    Acta Neuropathol; 2013 Apr; 125(4):523-33. PubMed ID: 23338750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Globular Glial Mixed Four Repeat Tau and TDP-43 Proteinopathy with Motor Neuron Disease and Frontotemporal Dementia.
    Takeuchi R; Toyoshima Y; Tada M; Tanaka H; Shimizu H; Shiga A; Miura T; Aoki K; Aikawa A; Ishizawa S; Ikeuchi T; Nishizawa M; Kakita A; Takahashi H
    Brain Pathol; 2016 Jan; 26(1):82-94. PubMed ID: 25787090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathologic Involvement of Glutamatergic Striatal Inputs From the Cortices in TAR DNA-Binding Protein 43 kDa-Related Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis.
    Riku Y; Watanabe H; Yoshida M; Mimuro M; Iwasaki Y; Masuda M; Ishigaki S; Katsuno M; Sobue G
    J Neuropathol Exp Neurol; 2017 Sep; 76(9):759-768. PubMed ID: 28859339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of the Hohara focus of the Kii Peninsula: A multiple proteinopathy?
    Mimuro M; Yoshida M; Kuzuhara S; Kokubo Y
    Neuropathology; 2018 Feb; 38(1):98-107. PubMed ID: 29063640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple Proteinopathies in Familial ALS Cases With Optineurin Mutations.
    Ayaki T; Ito H; Komure O; Kamada M; Nakamura M; Wate R; Kusaka H; Yamaguchi Y; Li F; Kawakami H; Urushitani M; Takahashi R
    J Neuropathol Exp Neurol; 2018 Feb; 77(2):128-138. PubMed ID: 29272468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.